Adjustable intragastric balloon for obesity

We agree with Barham K Abu Dayyeh and colleagues1 that “invasiveness, expense, long-term risks, and patients’ acceptance” reduce the popularity of bariatric surgery, which they demonstrate in the context of a well designed multicentre, randomised trial that supports the safety and efficacy of the adjustable intragastric balloon.